Shire rejects Takeda’s $63 billion offer

FAN Editor

article (REUTERS/Suzanne Plunkett/File Photo) Japan’s Takeda Pharmaceutical shares fell on Friday after rare disease drug maker Shire rejected its $63 billion cash-and-stock acquisition offer Continue Reading Below Shire said it had received three conditional proposals from Takeda, but said they significantly undervalued the company’s growth prospects and drugs in development. […]